Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

The importance of this technique becomes even clearer when considering the larger context. An astonishing 100 million ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Thousands of people with severe obesity are being denied access to effective treatment because the NHS rollout of the ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...

A new American Heart Association scientific statement suggests addressing cardiovascular health earlier in life may reduce the risk of stroke and help preserve thinking and memory later in life.